116 related articles for article (PubMed ID: 10499142)
1. Ischaemic heart disease as an effect of obesity-related metabolic disturbances.
Indulski JA; Lutz W
Cent Eur J Public Health; 1999 Aug; 7(3):122-9. PubMed ID: 10499142
[TBL] [Abstract][Full Text] [Related]
2. Metabolic and health complications of obesity.
Grundy SM; Barnett JP
Dis Mon; 1990 Dec; 36(12):641-731. PubMed ID: 2261844
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
Reaven GM
Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
[TBL] [Abstract][Full Text] [Related]
5. Adipose tissue dysfunction in obesity.
Blüher M
Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
[TBL] [Abstract][Full Text] [Related]
6. Metabolic implications of dietary trans-fatty acids.
Dorfman SE; Laurent D; Gounarides JS; Li X; Mullarkey TL; Rocheford EC; Sari-Sarraf F; Hirsch EA; Hughes TE; Commerford SR
Obesity (Silver Spring); 2009 Jun; 17(6):1200-7. PubMed ID: 19584878
[TBL] [Abstract][Full Text] [Related]
7. Trans fat intake lowers total cholesterol and high-density lipoprotein cholesterol levels without changing insulin sensitivity index in Wistar rats.
Huang Z; Wang B; Pace RD; Yoon S
Nutr Res; 2009 Mar; 29(3):206-12. PubMed ID: 19358935
[TBL] [Abstract][Full Text] [Related]
8. Insulin sensitivity indices of glucose and free fatty acid metabolism in obese children and adolescents in relation to serum lipids.
Reinehr T; Kiess W; Andler W
Metabolism; 2005 Mar; 54(3):397-402. PubMed ID: 15736120
[TBL] [Abstract][Full Text] [Related]
9. Impact of obesity in primary hyperlipidemias.
Carmena R; Ascaso JF; Real JT
Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):354-9. PubMed ID: 11887432
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiologic changes in obesity.
Angel A
Can Med Assoc J; 1978 Dec; 119(12):1401-6. PubMed ID: 737617
[TBL] [Abstract][Full Text] [Related]
11. Relationship of body fat distribution by waist circumference, dual-energy X-ray absorptiometry and ultrasonography to insulin resistance by homeostasis model assessment and lipid profile in obese and non-obese postmenopausal women.
dos Santos RE; Aldrighi JM; Lanz JR; Ferezin PC; Marone MM
Gynecol Endocrinol; 2005 Nov; 21(5):295-301. PubMed ID: 16373250
[TBL] [Abstract][Full Text] [Related]
12. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
13. Impact of obesity and body fat distribution on cardiovascular risk factors in Hong Kong Chinese.
Thomas GN; Ho SY; Lam KS; Janus ED; Hedley AJ; Lam TH;
Obes Res; 2004 Nov; 12(11):1805-13. PubMed ID: 15601976
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
15. The effect of abdominal obesity on insulin sensitivity and serum lipid and cytokine concentrations in African women.
Crowther NJ; Ferris WF; Ojwang PJ; Rheeder P
Clin Endocrinol (Oxf); 2006 May; 64(5):535-41. PubMed ID: 16649973
[TBL] [Abstract][Full Text] [Related]
16. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
Annuzzi G; Giacco R; Patti L; Di Marino L; De Natale C; Costabile G; Marra M; Santangelo C; Masella R; Rivellese AA
Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693
[TBL] [Abstract][Full Text] [Related]
17. [Cardiovascular risk factors and prevention in women: similarities and differences].
Sclavo M
Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
[TBL] [Abstract][Full Text] [Related]
18. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
[TBL] [Abstract][Full Text] [Related]
19. LDL particle size, fat distribution and insulin resistance in obese children.
Miyashita M; Okada T; Kuromori Y; Harada K
Eur J Clin Nutr; 2006 Mar; 60(3):416-20. PubMed ID: 16278685
[TBL] [Abstract][Full Text] [Related]
20. Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice.
Coenen KR; Hasty AH
Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E492-9. PubMed ID: 17566116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]